drugset / Trial / NCT01470001

The Effect of Solifenacin on Post Void Dribbling in Women

NCT01470001

Completed 118 enrolled University of Wisconsin, Madison
RandomizedParallel-groupDouble-blindTreatment

Summary

This is a double-blind, randomized, controlled, parallel design (n=140) study with the purpose of measuring the efficacy of Solifenacin 5mg in the treatment of women with Post Void Dribbling.

Timeline

Start
2011-11
Primary completion
2015-09
Completion
2015-09

Drugs

EvaluationDrugModalityDoseRoute
Comparator Solifenacin Small molecule 5 mg

Indications

No indication recorded.